J. Goldman & Co’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Sell |
121,500
-464,735
| -79% | -$1.77M | 0.01% | 277 |
|
|
2025
Q1 | $1.54M | Sell |
586,235
-632,892
| -52% | -$1.66M | 0.04% | 213 |
|
|
2024
Q4 | $4.32M | Sell |
1,219,127
-160,866
| -12% | -$569K | 0.11% | 156 |
|
|
2024
Q3 | $6.29M | Buy |
1,379,993
+509,656
| +59% | +$2.32M | 0.18% | 99 |
|
|
2024
Q2 | $3.79M | Sell |
870,337
-248,308
| -22% | -$1.08M | 0.11% | 137 |
|
|
2024
Q1 | $5.62M | Sell |
1,118,645
-285,962
| -20% | -$1.44M | 0.18% | 102 |
|
|
2023
Q4 | $8.81M | Buy |
1,404,607
+1,316,700
| +1,498% | +$8.26M | 0.36% | 62 |
|
|
2023
Q3 | $626K | Buy |
87,907
+31,655
| +56% | +$225K | 0.02% | 167 |
|
|
2023
Q2 | $573K | Sell |
56,252
-11,250
| -17% | -$115K | 0.02% | 186 |
|
|
2023
Q1 | $612K | Sell |
67,502
-109,587
| -62% | -$994K | 0.02% | 177 |
|
|
2022
Q4 | $1.27M | Buy |
177,089
+126,464
| +250% | +$907K | 0.06% | 156 |
|
|
2022
Q3 | $330K | Buy |
+50,625
| New | +$330K | 0.02% | 222 |
|
|
2022
Q2 | – | Sell |
-67,500
| Closed | -$383K | – | 339 |
|
|
2022
Q1 | $383K | Sell |
67,500
-302,591
| -82% | -$1.72M | 0.02% | 214 |
|
|
2021
Q4 | $1.86M | Sell |
370,091
-422,330
| -53% | -$2.12M | 0.1% | 156 |
|
|
2021
Q3 | $5.27M | Buy |
792,421
+71,544
| +10% | +$476K | 0.26% | 71 |
|
|
2021
Q2 | $4.41M | Buy |
720,877
+522,451
| +263% | +$3.19M | 0.17% | 116 |
|
|
2021
Q1 | $1.32M | Buy |
+198,426
| New | +$1.32M | 0.04% | 209 |
|